Institutional Ownership Silence Therapeutics PLC (SLN)
This table provides information about the institutional ownership of Silence Therapeutics PLC (SLN). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 22.7 Million shares, which have been reported (via 13F filing form) to have a value of $141 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
2,367
shares
|
$14,722
0.0% of portfolio
|
Q1 2025
Added 274.53%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
1,875
shares
|
$11,662
0.0% of portfolio
|
Q4 2024
Reduced 55.15%
|
|
|
Mirae Asset Global Investments Co., Ltd.
|
Apr 24, 2025 Q1 2025 |
1,573
shares
|
$9,784
0.0% of portfolio
|
Q1 2025
Added 0.45%
|
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
1,300
shares
|
$8,086
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Gf Fund Management Co. Ltd.
Guangzhou, F4 |
Apr 28, 2025 Q1 2025 |
1,165
shares
|
$7,246
0.0% of portfolio
|
Q1 2025
Added 18.03%
|
|
|
Simplex Trading, LLC
|
May 12, 2025 Q1 2025 |
251
shares
|
$1,561
0.0% of portfolio
|
Q1 2025
Added 392.16%
|
|
|
Steward Partners Investment Advisory, LLC
|
May 13, 2025 Q1 2025 |
100
shares
|
$622
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
28
shares
|
$174
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|